Kennedy Capital Management, Inc. Ovid Therapeutics Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 1,545,387 shares of OVID stock, worth $958,139. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,545,387
Previous 1,527,985
1.14%
Holding current value
$958,139
Previous $1.8 Million
20.3%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$3.3 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.48 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.39 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$2.31 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.95 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $43.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...